דילוג לניווט ראשי
דילוג לחיפוש
דילוג לתוכן הראשי
מיון לפי
Keyphrases
Follicular Lymphoma
100%
Anthracycline Therapy
100%
Confidence Interval
58%
Anthracyclines
58%
Risk Ratio
41%
Disease Control
33%
Overall Survival
33%
Hazard Ratio
25%
Chemotherapy Regimen
25%
Non-anthracycline
25%
Chemotherapy
16%
Randomized Controlled Trial
16%
Cardiotoxicity
16%
Progression-free Survival
16%
Survival Duration
16%
Risk Response
16%
Remission Duration
16%
Adult Patients
8%
Patient Management
8%
MEDLINE
8%
Meta-analysis
8%
Complete Response
8%
Rate of Increase
8%
Search Methods
8%
Risk Reduction
8%
Cochrane Library
8%
Selection Criteria
8%
Unblinding
8%
Conference Proceedings
8%
Stem Cell Transplantation
8%
Fixed Effects Model
8%
Serious Infection
8%
Control Arm
8%
Lymphoma Patients
8%
Hazard Risk
8%
Peer-reviewed Journals
8%
Control Hazard
8%
Cochrane Central Register of Controlled Trials
8%
Rituximab
8%
Review Authors
8%
Issue 3
8%
Naïve Patients
8%
Outcome Definition
8%
Radiotherapy Alone
8%
Cytopenia
8%
Therapy-naïve
8%
Extracted Data
8%
Statistically Significant Difference
8%
Trial Data
8%
Medical Libraries
8%
Small Database
8%
Nursing and Health Professions
Follicular Lymphoma
100%
Anthracycline
100%
Confidence Interval
36%
Disease Control
21%
Overall Survival
21%
Hazard Ratio
15%
Chemotherapy
15%
Immunotherapy
10%
Remission
10%
Cochrane Library
10%
Progression Free Survival
10%
Cardiotoxicity
10%
Infection
5%
Meta Analysis
5%
Rituximab
5%
Stem Cell Therapy
5%
Cytopenia
5%
Radiotherapy
5%
Side Effect
5%
Efficacy
5%
Medicine and Dentistry
Follicular Lymphoma
100%
Anthracycline
100%
Arm
26%
Overall Survival
21%
Diseases
21%
Hazard Ratio
15%
Chemotherapy
15%
Randomized Controlled Trial
10%
Immunotherapy
10%
Progression Free Survival
10%
Cardiotoxicity
10%
Meta-Analysis
5%
Infection
5%
Stem Cell Therapy
5%
Rituximab
5%
Cytopenia
5%
Radiation Therapy
5%
Side Effect
5%
Medical Library
5%
Immunology and Microbiology
Arm
100%
Overall Survival
80%
Immunotherapy
40%
Progression Free Survival
40%
Cochrane Library
40%
Stem Cell Transplantation
20%
Infectious Disease
20%
Rituximab
20%
Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Follicular Lymphoma
100%
Anthracycline
100%
Overall Survival
21%
Diseases
21%
Chemotherapy Regimens
15%
Randomized Controlled Trial
10%
Remission
10%
Immunotherapy
10%
Cardiotoxicity
10%
Progression Free Survival
10%
Infection
5%
Rituximab
5%
Cytopenia
5%
Side Effect
5%
Social Sciences
Legal Procedure
100%
Confidence Interval
53%
Disease Control
30%
Authors
23%
Randomized Controlled Trial
15%
Value Added
7%
Infectious Disease
7%
Meta-Analysis
7%
Fixed Effects Model
7%
Conference Papers
7%
Arms Control
7%
Medical Library
7%